<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

ArthroFree: The Surgical Camera for the Wireless Era

By Andy Knapik on 8/2/23 3:39 PM

In a joint interview with Eugene Malinskiy, founder and CEO of Lazurite, and orthopedic surgeon Dr James Voos, we discuss the world’s first wireless surgical camera, the Lazurite ArthroFree camera.

Eugene Malinskiy, the founder and CEO of Lazurite, and orthopedic surgeon Dr. James Voos discuss the technological and clinical benefits of the new ArthroFree camera, the world’s first fully wireless surgical camera, with Andy Knapik, SmartTRAK's Senior Analyst, Soft Tissue & Arthroscopic Technologies.

To learn more about Lazurite and the ArthroFree System, click the following video to watch the interview (27:05 min).  For more details, interview topics by timecode are provided below. To download a complete transcript of the interview, click here.

 

Interview Topics By Timecode

1:25 Background of Lazurite and the ArthroFree camera.

7:05 Surgeon impressions of the ArthroFree camera.

10:10 Camera integration, image quality, battery life, ergonomics.

16:05 How the camera connects to the monitor and image capture.

19:22 How do facilities react to purchasing the ArthroFree.

22:05 Uses of the ArthroFree camera.

To download the complete transcript of the interview with Eugene Malinskiy, the founder and CEO of Lazurite, and orthopedic surgeon Dr. James Voos, just click the button below. Download the Transcript

Continue Reading
3 min read

Setting the Stage for Growth: Q123 Ortho Enabling Tech Market Recap

By Shelly Caruso on 6/26/23 10:19 AM

Continued strength in ortho robotics placements and a crowd of new product launches in Q123 set the stage for growth in the remainder of the year.

The Q123 US Ortho Enabling Tech Market declined slightly by -0.6% YoY according to SmartTRAK Financial Dashboard . Stryker* (SYK) remained the market leader with 55.6% share, followed by Smith+Nephew* ( SNN), Zimmer Biomet* (ZBH) and DePuy Synthes* (JNJ). For detailed Q132 revenues and shares by company in the US, EU and ROW, see SmartTRAK Ortho Enabling Tech Financial Dashboard .


Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Ortho Enabling Tech Market Recap* are:

  • Complete Q123 Otho Enabling Tech Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All US Ortho Enabling Tech Companies' News, Revenues, Data, Charts and Market Shares
  • Robust Q123 Robotics Performances by Company
    • Stryker
    • Zimmer Biomet
    • Smith+Nephew
    • JNJ/Depuy Synthes
  • New Product Introductions
    • Robotics and Ecosystem Launches
    • Navigation and Planning Innovations
  • SmartTRAK's Selected Highlights from Q123 Conferences
    • JP Morgan 41st Annual Healthcare Conference
    • Canaccord Genuity 2023 Musculoskeletal Conference
    • AAOS 2023 Annual Meeting

In an International Society for Technology in Arthroplasty (ISTA) presentation at the American Academy of Orthopaedic Surgeons 2023 (AAOS 2023) Annual Meeting, President, Digital, Robotics and Enabling Technology at SYK Robert Cohen discussed innovations including a fully connected operating room for a common user experience with planning and mixed-reality guidance combined with robotics and data transfer capabilities. Enabling technology continues to see adoption and integration in orthopedics and with it, the introduction of ...

Read the entire Q123 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.Learn More about Subscribing to SmartTRAK

Continue Reading
2 min read

A Banner Year: Q422 Ortho Enabling Tech Market Recap

By Elise Wolf on 5/4/23 9:45 AM

Q422 was a banner quarter for ortho enabling tech installations, technological advances and expanding applications on the horizon.

The Q422 WW Ortho Enabling Tech Market was down -7.2% YoY, according to SmartTRAK Financial Dashboard . Stryker (SYK) remained the market leader with 65.1% share, followed by Smith+Nephew (SNN), Zimmer Biomet (ZBH) and DePuy Synthes (JNJ). For detailed Q422 revenues and shares by company in the US, EU and ROW, see the SmartTRAK Ortho Enabling Tech Financial Dashboard .*
 
Among the many topics explored in detail in this comprehensive article are:
  • Strong Robotic Performance Despite Lackluster Revenue from Changing Deal Mix
  • Expanding Robotic Applications Contribute to Growth
  • Other Orthopedic Robotics Moving Forward
  • Orthopedic Enabling Tech Making Inroads into Spine and Vice Versa
  • Navigation Highlights
  • Advances in Augmented Reality
  • Preoperative Planning Highlights

Orthopedic robotics market leader SYK reported that Q422 was a record quarter for MAKO installations, both in the US and internationally, with an unsurpassed number of MAKO installations in ASCs. In Q422, SYK saw ...

Read the entire Q422 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Learn More about Subscribing to SmartTRAK

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles